No Data
No Data
Express News | Wedbush Reiterates Outperform on Ikena Oncology, Maintains $8 Price Target
Ikena Oncology (IKNA) Gets a Buy From Wedbush
Express News | Ikena Oncology Inc: Ik-930 Program on Track to Deliver Clinical Update in 2H 2024
Express News | Ikena Oncology Inc: Strong Financial Position With $157.3 Mln; Runway Into 2H 2026
Express News | Ikena Oncology Q1 EPS $(0.33) Beats $(0.41) Estimate
Ikena Oncology 1Q Loss/Shr 33c >IKNA
Ikena Oncology 1Q Loss/Shr 33c >IKNA
No Data